Antiobesity properties of two African plants (Afromomum meleguetta and Spilanthes acmella) by pancreatic lipase inhibition

Phytotherapy Research

Volumn 21, Issue 12, 2007, Pages 1253-1255

  Ekanem, A P ^a   Wang, M ^b   Simon, J E ^b   Moreno, D A ^c  

^a UNIVERSITY OF CALABAR   (Nigeria)

^b RUTGERS UNIVERSITY   (United States)

^c Campus Universitario de Espinardo   (Spain)

Author keywords

Afromomum meleguetta; Lipase inhibition; Spilanthes acmella

Indexed keywords

AFROMOMUM MELEGUETTA EXTRACT; HERBACEOUS AGENT; SPILANTHES ACMELLA EXTRACT; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

AFROMOMUM MELEGUETTA; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; OBESITY; SPILANTHES ACMELLA; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; ASTERACEAE; DIETARY FATS; FLOWERS; LIPASE; PLANT EXTRACTS; SEEDS; ZINGIBERACEAE;

ACMELLA; SPILANTHES ACMELLA;

EID: 37848999018     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2239     Document Type: Article

References (24)

1. Agharkar SP. 1991. Medicinal Plants of Bombay Presidency. Pbl. Scientific publishers: Jodhpur, India, 200-201.
2. Ballinger A, Peikin SIR. 2002. Orlistat: its current status as an anti-obesity drug. Eur J Pharm 440: 109.
3. Bond DS, Evans RK, DeMaria EJ et al. 2004. A conceptual application of health behavior theory in the design and implementation of a successful surgical weight loss program. Obesity Surg 14: 849-856.
4. Bray GA. 2002. The underlying basis for obesity: relationship to cancer. J Nutr 132: 3451S-3455S.
5. Bray GA. 2004. Obesity is a chronic relapsing neurochemical disease. Int J Obesity 28: 34-38.
6. Caterson ID. 1999. Obesity and its management. Austr Prescrib 22: 12-16.
7. Dokosi, O.B. 1998. Herbs of Ghana. Ghana University Press: Accra.
8. Dietz WM, Goodwin NJ, Yanovski SZ. 1996. Long-term pharmacotherapy in the management of obesity. JAMA 276: 1907-1915.
9. Enti AA. 1988. The Rejuvenating Plants of Tropical Africa, AK Andolf, FLS. The North Scale Institute: San Francisco.
10. Gokhale VG, Blude BV. 1945. Constituents of spilanthes. J Indian Chem Soc 22: 250.
11. Guerciolini R. 1997. Mode of action of Orlistat. Int J Obesity Relat Metab Disord 21 (suppl. 3): S12-S23.
12. Hensrud DV. 2004. Diet and obesity. Curr Op Gastroenterol 20: 119-124.
13. Iwu M. 1993. Handbook of African Medicinal Plants. CRC Press: Boca Raton, FL.
14. Juhel C, Armand M, Pafumi Y, Rosier J, Vandermander J, Lairon D. 2000. Green tea extract (AR25®) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J Nutr Biochem 11: 45-51.
15. Kirby GC. 1996. Medicinal plants and the control of protozoal disease with particular reference to malaria. Trans R Soc Trop Med Hyg 90: 605-609.
16. Moreno DA, Ilic N, Poulev A, Brasaemle DL, Fried SK, Raskin I. 2003. Inhibitory effects of grape seed extract on lipases. Nutrition 19: 876-879.
17. Piechowski-Jozwiak B, Bogousslavsky J. 2004. Stroke prevention with lipid-lowering therapy. Expert Rev Neurother 4: 233-239.
18. Pittler MH, Ernst E. 2004. Dietary supplements for body-weight reduction. Am J Clin Nutr 79: 529-535.
19. Rippe JM, Crossley S, Ringer R. 1998. Obesity as a chronic disease: Modern medical and lifestyle management. J Am Diet Assoc 98: S9-S15.
20. Tackie AN, Dwuma-Badu D, Ayim JSK et al. 1975. Hydroxyphenylalkanones from Amomum melegueta. Phytochemistry 14: 853-854.
21. Tsutsumi K, Kwawauchi Y, Kondo Y, Inoue Y, Koshitani O, Kohri H. 2000. Water extract of defatted rice bran suppresses visceral fat accumulation in rats. J Agric Food Chem 48: 1653-1656.
22. Verma DM, Balakrishnan NP, Dixit RD. 1993. Flora of Madhya Pradesh Vol. 1 Pbl. Botanical Survey of India: Kolkata, 612-613.
23. Yanovski SZ, Yanovski JA. 2002. Obesity. N Engl J Med 346: 591.
24. Yoshukaval M, Shimoda H, Nishida N, Takada M, Matsuda H. 2002. Salacta reticulata and its polyphenols constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats. J Nutr 123: 1819-1824.